These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 20091076)

  • 1. Anti-agalactosyl IgG antibodies in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.
    Louthrenoo W; Kasitanon N; Wichainun R; Wangkaew S; Sukitawut W; Kuwata S; Takeuchi F
    Clin Rheumatol; 2010 Mar; 29(3):241-6. PubMed ID: 20091076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis.
    Ryu HJ; Takeuchi F; Kuwata S; Kim YJ; Lee EY; Lee EB; Song YW
    Rheumatol Int; 2011 Mar; 31(3):315-9. PubMed ID: 20012964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of anti-agalactosyl IgG antibodies, rheumatoid factors, and anti-cyclic citrullinated peptide antibodies in the differential diagnosis of rheumatoid arthritis and its mimics.
    Lu MC; Hsieh SC; Lai NS; Li KJ; Wu CH; Yu CL
    Clin Exp Rheumatol; 2007; 25(5):716-21. PubMed ID: 18078619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CCP antibodies and rheumatoid factor in systemic sclerosis: Prevalence and relationships with joint manifestations.
    Wielosz E; Majdan M; Dryglewska M; Zwolak R
    Adv Clin Exp Med; 2018 Sep; 27(9):1253-1257. PubMed ID: 30024658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies.
    Jaskowski TD; Hill HR; Russo KL; Lakos G; Szekanecz Z; Teodorescu M
    J Rheumatol; 2010 Aug; 37(8):1582-8. PubMed ID: 20516016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis.
    Nishijima C; Sato S; Takehara K
    J Rheumatol; 2001 Aug; 28(8):1847-51. PubMed ID: 11508588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis.
    Ueda-Hayakawa I; Hasegawa M; Kumada S; Tanaka C; Komura K; Hamaguchi Y; Takehara K; Fujimoto M
    Rheumatology (Oxford); 2010 Nov; 49(11):2135-9. PubMed ID: 20663814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cyclic citrullinated peptide antibody in systemic sclerosis.
    Morita Y; Muro Y; Sugiura K; Tomita Y
    Clin Exp Rheumatol; 2008; 26(4):542-7. PubMed ID: 18799082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis.
    Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Yazawa N; Tamaki K
    Br J Dermatol; 2004 Oct; 151(4):803-8. PubMed ID: 15491420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.
    Lakos G; Soós L; Fekete A; Szabó Z; Zeher M; Horváth IF; Dankó K; Kapitány A; Gyetvai A; Szegedi G; Szekanecz Z
    Clin Exp Rheumatol; 2008; 26(2):253-60. PubMed ID: 18565246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
    Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
    Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement.
    Ribeiro SL; Pereira HL; Silva NP; Neves RM; Sato EI
    Braz J Med Biol Res; 2008 Nov; 41(11):1005-10. PubMed ID: 19099154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
    Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
    Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of rheumatoid factor isotypes and anti-cyclic citrullinated peptides in Malaysian rheumatoid arthritis patients.
    Gomez EL; Gun SC; Somnath SD; D'Souza B; Lim AL; Chinna K; Radhakrishnan AK
    Int J Rheum Dis; 2011 Feb; 14(1):12-7. PubMed ID: 21303477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.
    Popescu C; Zofotă S; Bojincă V; Ionescu R
    Rom J Intern Med; 2013; 51(3-4):179-87. PubMed ID: 24620631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
    Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
    J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior specificity of anti-citrullinated peptide antibodies in patients with chronic lymphocytic leukemia and arthritis.
    Brickmann K; Brezinschek RI; Yazdani-Biuki B; Graninger WB; Brezinschek HP
    Clin Exp Rheumatol; 2010; 28(6):888-91. PubMed ID: 21205465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis.
    dos Anjos LM; Pereira IA; d 'Orsi E; Seaman AP; Burlingame RW; Morato EF
    Clin Rheumatol; 2009 Feb; 28(2):153-8. PubMed ID: 18795390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.